LPL Financial’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.67M Buy
138,371
+19,758
+17% +$524K ﹤0.01% 2548
2025
Q1
$2.86M Buy
118,613
+21,911
+23% +$529K ﹤0.01% 2604
2024
Q4
$3.89M Buy
96,702
+14,873
+18% +$598K ﹤0.01% 2263
2024
Q3
$5.18M Buy
81,829
+24,326
+42% +$1.54M ﹤0.01% 1954
2024
Q2
$3.05M Buy
57,503
+4,516
+9% +$239K ﹤0.01% 2230
2024
Q1
$4.34M Buy
52,987
+3,352
+7% +$275K ﹤0.01% 1890
2023
Q4
$924K Buy
49,635
+13,820
+39% +$257K ﹤0.01% 3084
2023
Q3
$396K Sell
35,815
-2,557
-7% -$28.3K ﹤0.01% 3636
2023
Q2
$622K Buy
38,372
+5,767
+18% +$93.5K ﹤0.01% 3216
2023
Q1
$543K Sell
32,605
-11,045
-25% -$184K ﹤0.01% 3238
2022
Q4
$410K Buy
43,650
+4,031
+10% +$37.9K ﹤0.01% 3415
2022
Q3
$108K Sell
39,619
-74
-0.2% -$202 ﹤0.01% 4057
2022
Q2
$115K Buy
39,693
+13,542
+52% +$39.2K ﹤0.01% 4071
2022
Q1
$78K Sell
26,151
-1,365
-5% -$4.07K ﹤0.01% 3996
2021
Q4
$127K Sell
27,516
-4,849
-15% -$22.4K ﹤0.01% 4075
2021
Q3
$203K Buy
32,365
+5,470
+20% +$34.3K ﹤0.01% 3952
2021
Q2
$161K Buy
26,895
+1,500
+6% +$8.98K ﹤0.01% 3939
2021
Q1
$161K Buy
25,395
+11,000
+76% +$69.7K ﹤0.01% 3806
2020
Q4
$81K Hold
14,395
﹤0.01% 3686
2020
Q3
$84K Sell
14,395
-4,000
-22% -$23.3K ﹤0.01% 3375
2020
Q2
$133K Sell
18,395
-7,725
-30% -$55.9K ﹤0.01% 3214
2020
Q1
$122K Buy
26,120
+8,450
+48% +$39.5K ﹤0.01% 2941
2019
Q4
$142K Sell
17,670
-3,698
-17% -$29.7K ﹤0.01% 3159
2019
Q3
$147K Buy
21,368
+4,183
+24% +$28.8K ﹤0.01% 3083
2019
Q2
$143K Sell
17,185
-128,600
-88% -$1.07M ﹤0.01% 3094
2019
Q1
$1.45M Buy
+145,785
New +$1.45M ﹤0.01% 1390